Protocol for automated production of human stem cell derived liver spheres

Summary: This protocol describes how to produce human liver spheres from pluripotent stem cell-derived hepatic progenitors, endothelial cells, and hepatic stellate cells. Liver spheres form by self-assembly in microwells, generating up to 73 spheres per well of a 96-well plate. This process was auto...

Full description

Bibliographic Details
Main Authors: Jose Meseguer-Ripolles, Alvile Kasarinaite, Baltasar Lucendo-Villarin, David C. Hay
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:STAR Protocols
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666166721002094
id doaj-c545e9cb181540ee87b21a9245f16b38
record_format Article
spelling doaj-c545e9cb181540ee87b21a9245f16b382021-06-21T04:25:26ZengElsevierSTAR Protocols2666-16672021-06-0122100502Protocol for automated production of human stem cell derived liver spheresJose Meseguer-Ripolles0Alvile Kasarinaite1Baltasar Lucendo-Villarin2David C. Hay3Centre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, 5 Little France Drive, Edinburgh EH16 4UU, UK; Corresponding authorCentre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, 5 Little France Drive, Edinburgh EH16 4UU, UKCentre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, 5 Little France Drive, Edinburgh EH16 4UU, UKCentre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, 5 Little France Drive, Edinburgh EH16 4UU, UK; Corresponding authorSummary: This protocol describes how to produce human liver spheres from pluripotent stem cell-derived hepatic progenitors, endothelial cells, and hepatic stellate cells. Liver spheres form by self-assembly in microwells, generating up to 73 spheres per well of a 96-well plate. This process was automated using liquid handling and pipetting systems, permitting cost-effective scale-up and reducing sphere variability. In its current form, this system provides a powerful tool to generate human liver tissue for disease modeling and drug screening.For complete details on the use and execution of this protocol, please refer to Lucendo-Villarin et al. (2020) (https://doi.org/10.1088/1758-5090/abbdb2).http://www.sciencedirect.com/science/article/pii/S2666166721002094MetabolismStem CellsCell DifferentiationTissue Engineering
collection DOAJ
language English
format Article
sources DOAJ
author Jose Meseguer-Ripolles
Alvile Kasarinaite
Baltasar Lucendo-Villarin
David C. Hay
spellingShingle Jose Meseguer-Ripolles
Alvile Kasarinaite
Baltasar Lucendo-Villarin
David C. Hay
Protocol for automated production of human stem cell derived liver spheres
STAR Protocols
Metabolism
Stem Cells
Cell Differentiation
Tissue Engineering
author_facet Jose Meseguer-Ripolles
Alvile Kasarinaite
Baltasar Lucendo-Villarin
David C. Hay
author_sort Jose Meseguer-Ripolles
title Protocol for automated production of human stem cell derived liver spheres
title_short Protocol for automated production of human stem cell derived liver spheres
title_full Protocol for automated production of human stem cell derived liver spheres
title_fullStr Protocol for automated production of human stem cell derived liver spheres
title_full_unstemmed Protocol for automated production of human stem cell derived liver spheres
title_sort protocol for automated production of human stem cell derived liver spheres
publisher Elsevier
series STAR Protocols
issn 2666-1667
publishDate 2021-06-01
description Summary: This protocol describes how to produce human liver spheres from pluripotent stem cell-derived hepatic progenitors, endothelial cells, and hepatic stellate cells. Liver spheres form by self-assembly in microwells, generating up to 73 spheres per well of a 96-well plate. This process was automated using liquid handling and pipetting systems, permitting cost-effective scale-up and reducing sphere variability. In its current form, this system provides a powerful tool to generate human liver tissue for disease modeling and drug screening.For complete details on the use and execution of this protocol, please refer to Lucendo-Villarin et al. (2020) (https://doi.org/10.1088/1758-5090/abbdb2).
topic Metabolism
Stem Cells
Cell Differentiation
Tissue Engineering
url http://www.sciencedirect.com/science/article/pii/S2666166721002094
work_keys_str_mv AT josemeseguerripolles protocolforautomatedproductionofhumanstemcellderivedliverspheres
AT alvilekasarinaite protocolforautomatedproductionofhumanstemcellderivedliverspheres
AT baltasarlucendovillarin protocolforautomatedproductionofhumanstemcellderivedliverspheres
AT davidchay protocolforautomatedproductionofhumanstemcellderivedliverspheres
_version_ 1721369037625098240